Caliway Biopharmaceuticals Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	2,650	3,422	655.05	594.91	93.56	21.69
Short-Term Investments	689.4	289.4	456.18	-	-	-
Cash & Short-Term Investments	3,340	3,712	1,111	594.91	93.56	21.69
Cash Growth	283.70%	234.01%	86.79%	535.87%	331.36%	-
Accounts Receivable	4.52	7.89	3.12	-	-	3.2
Other Receivables	-	-	-	-	-	4.46
Receivables	4.52	7.89	3.12	-	-	7.66
Inventory	5.66	1.02	2.81	0.05	2.53	0.02
Other Current Assets	17.45	23.16	14.87	10.32	14.96	9.08
Total Current Assets	3,367	3,744	1,132	605.27	111.05	38.45
Property, Plant & Equipment	73.49	80.41	99.6	106.38	114.68	128.99
Other Intangible Assets	-	-	-	-	0.07	1.66
Other Long-Term Assets	2.89	2.46	1.46	1.26	1.26	1.26
Total Assets	3,444	3,827	1,233	712.9	227.05	170.35
Accounts Payable	1.72	1.7	2.53	0.33	0.74	1.04
Accrued Expenses	-	-	-	30.98	45.14	19.96
Short-Term Debt	-	-	-	-	-	5
Current Portion of Long-Term Debt	-	-	-	1.17	7.97	74.72
Current Portion of Leases	8.79	8.58	8.22	7.03	6.79	6.49
Current Unearned Revenue	9.41	1.03	4.5	-	-	-
Other Current Liabilities	60.43	62.37	33.11	0.16	3.82	3.2
Total Current Liabilities	80.35	73.68	48.36	39.67	64.45	110.4
Long-Term Debt	-	-	-	3.55	83.95	30.41
Long-Term Leases	7.46	11.87	20.46	25.02	32.06	38.85
Total Liabilities	87.81	85.55	68.82	68.24	180.46	179.66
Common Stock	697.19	696.62	615.55	535.93	312.17	244.71
Additional Paid-In Capital	3,053	3,271	834.46	217.47	106.85	18.6
Retained Earnings	-395.12	-227.31	-286.16	-107.41	-371.05	-272.56
Treasury Stock	-0.06	-0.07	-0.08	-0.09	-	-
Comprensive Income & Other	1.09	0.81	0.49	-1.24	-1.38	-0.06
Shareholders' Equity	3,356	3,741	1,164	644.66	46.6	-9.31
Total Liabilities & Equity	3,444	3,827	1,233	712.9	227.05	170.35
Total Debt	16.25	20.46	28.68	36.78	130.76	155.46
Net Cash (Debt)	3,324	3,691	1,083	558.13	-37.2	-133.77
Net Cash Growth	292.93%	240.96%	93.96%	-	-	-
Net Cash Per Share	25.17	29.79	9.24	6.07	-0.50	-1.91
Filing Date Shares Outstanding	139.42	139.3	123.11	107.16	83.29	69.92
Total Common Shares Outstanding	139.42	139.3	123.11	107.16	83.29	69.92
Working Capital	3,287	3,670	1,084	565.6	46.6	-71.96
Book Value Per Share	24.07	26.86	9.46	6.02	0.56	-0.13
Tangible Book Value	3,356	3,741	1,164	644.66	46.53	-10.96
Tangible Book Value Per Share	24.07	26.86	9.46	6.02	0.56	-0.16
Machinery	136.25	129.99	121.55	112.76	76.42	74.25
Construction In Progress	2.27	1.14	1.82	0.3	31.29	31.67

Source: S&P Capital IQ. Standard template. Financial Sources.